IEQ Capital’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
Other funds holding ENTA
IEQ Capital's ENTA Position: Q3 2026 in Review
IEQ Capital reduced its Enanta Pharmaceuticals (ENTA) stake by 47% in Q3 2026, selling an estimated $240K and leaving 20,466 shares worth $270K. The position accounts for ﹤0.01% of the portfolio, ranked #1644.
IEQ Capital first reported a position in ENTA in Q1 2025 and has held it in 7 quarters since. The position peaked at $574K in Q4 2025. 129 funds tracked by Wall St. Rank hold ENTA as of Q3 2026.
- IEQ Capital held 20,466 shares of Enanta Pharmaceuticals worth $270K as of Q3 2026.
- IEQ Capital sold 18,042 Enanta Pharmaceuticals shares in Q3 2026, an estimated $240K.
- Enanta Pharmaceuticals made up ﹤0.01% of IEQ Capital's portfolio in Q3 2026, its #1644 holding.
- IEQ Capital first reported a position in Enanta Pharmaceuticals in Q1 2025 and has held it in 7 quarters since.
- IEQ Capital's Enanta Pharmaceuticals position peaked at $574K in Q4 2025.
- 129 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q3 2026.
Based on IEQ Capital's 13F filing for Q3 2026, filed 10 Nov 2026.